Clinical Trial Update: Expression of PARP-1 in Multiple Sclerosis Patients [NA]

View source ↗

Summary

This clinical trial update indicates the study on PARP-1 expression in patients with Multiple Sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Sohag University | Conditions: Multiple Sclerosis | NA | Status: COMPLETED